GLP-1 analogue ameliorates the function of NK cells in people with obesity and activates NK cell-mediated anti-tumor responses in hepatocellular carcinoma (Lu et al., 2021; De Barra et al., 2023). This evidence concerns the gene GCG and hepatocellular carcinoma.